Market By Source Type, Methodology, Applications, Products & Services, End-users And Geography | Forecast 2019-2027
Triton predicts the global intraoperative neuromonitoring market to exhibit a CAGR of 5.36% with $3054 million in 2018 and is estimated to generate total revenue of around $5050 million by 2027 in the forecast years of 2019-2027.
Intraoperative neuromonitoring (IONM) is a crucial part of different surgical procedures. The initial use of intraoperative neuro testing dates back to the 1930s, at the time when direct stimulation of the cortical was performed to find out the motor cortex of epilepsy patients; but, it was with the introduction of the commercial intraoperative neuromonitoring machine in the 1980s that the method gained popularity.
Report scope can be customized per your requirements. Request For Customization
IONM has been used for reducing the neurological damage caused while performing surgery, identifying integral neural structures in the operation and thus, avoiding and/or limiting the significant postoperative impairments. Intraoperative neuromonitoring implements a wide variety of methodologies, each with a very specific application, with several methodologies often being used together in the same surgery.
Within this report from Triton on the global intraoperative neuromonitoring market, the market definition and key insights regarding the industry have been discussed. Also, the market attractiveness matrix, vendor scorecard, key buying criteria, value chain analysis and Porter’s five force analysis have been studied for the global intraoperative neuromonitoring market.
Drivers like the growing incidence of neurological disorders leading to surgeries, increasing geriatric population and technological advancements are fueling the market growth. However, the industry is facing restraints like high cost of devices & services which is obstructing the market growth.
Key opportunities like the emergence of remote intraoperative neuromonitoring and the rise in demand for minimally invasive neurosurgical procedures can be leveraged by the industry to get towards the projected growth. Challenges such as the availability of cheaper alternatives are being faced by the industry at the moment.
To get detailed insights on segments, Download Sample Report
Key geographies covered for the global intraoperative neuromonitoring market:
• North America: United States and Canada
• Europe: United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia-Pacific
• Latin America: Brazil, Mexico and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of Middle East & Africa
The intraoperative neuromonitoring market segmentation:
• Source type has been sub-segmented into:
O Insourced
O Outsourced
• Application has been sub-segmented into:
O Spinal surgery
O ENT surgery
O Neurosurgery
O Vascular surgery
O Orthopedic surgery
O Other surgeries
• Methodology has been sub-segmented into:
O EEG
O EMG
O EP
• SEP monitoring
• TCMEP monitoring
• BAEP monitoring
• VEP monitoring
• Products & Services has been sub-segmented into:
O System
O Accessories
O Services
• End-users has been sub-segmented into:
O Hospitals
O Ambulatory surgical centers (ASCs)
The top companies that have been studied in the intraoperative neuromonitoring market are Moberg Research Inc. (Dayone Medical LLC), Zynex, IntraNerve, ORIMtec, NeuroSentinel, Natus Medical, CNS Neuromonitoring, Medtronic, Accurate Neuromonitoring, Cadwell, NuVasive, Checkpoint Surgical, Nihon Kohden, Medsurant Monitoring, SpecialtyCare, EMOTIV, Inomed Medizintechnik GmbH, Neuromonitoring Technologies and Computational Diagnostics.
The strategic analysis for each of these companies in the intraoperative neuromonitoring market has been covered in detail. Company profiles help to dive into the information about the key market players in this industry and how much hold they have on the market. In spite of being technologically intensive, the immense growth opportunities are attracting new companies to rush into the market and thus accelerate the degree of competition.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1.
OUTSOURCED INTRAOPERATIVE NEUROMONITORING IS EXPECTED TO DOMINATE THE
MARKET
2.2.2.
EP IS A WIDELY USED METHODOLOGY OF INTRAOPERATIVE NEUROMONITORING
2.2.3.
SPINAL SURGERY IS THE LARGEST APPLICATION OF INTRAOPERATIVE NEUROMONITORING
2.2.4.
SERVICES SEGMENT IS GROWING AT A RAPID RATE
2.2.5.
AMBULATORY SURGICAL CENTERS (ASCs) ARE RAPIDLY ADOPTING INTRAOPERATIVE
NEUROMONITORING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1.
THREAT OF NEW ENTRANTS
2.3.2.
THREAT OF SUBSTITUTE
2.3.3.
BARGAINING POWER OF SUPPLIERS
2.3.4.
BARGAINING POWER OF BUYERS
2.3.5.
INTENSITY OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1.
INCREASING NEUROLOGICAL AND OTHER DISORDERS LEADING TO SURGERIES
2.6.2.
TECHNOLOGICAL ADVANCEMENT
2.6.3.
REDUCTION OF COMPLICATION DURING COMPLEX SURGERIES USING INTRAOPERATIVE
NEUROMONITORING
2.6.4.
INCREASING AGING POPULATION
2.7. MARKET RESTRAINTS
2.7.1.
HIGH COST OF IONM DEVICES AND SERVICES
2.7.2.
LACK OF SKILLED OPERATORS
2.8. MARKET OPPORTUNITIES
2.8.1.
RISE IN DEMAND FOR THE USE OF INTRAOPERATIVE NEUROMONITORING FOR
MINIMALLY INVASIVE SURGERIES
2.8.2.
DEVELOPMENT OF REMOTE INTRAOPERATIVE NEUROMONITORING
2.8.3.
EMERGENCE OF PORTABLE INTRAOPERATIVE NEUROMONITORING
2.9. MARKET CHALLENGES
2.9.1.
AVAILABILITY OF LESS COSTLY SUBSTITUTES
3.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY SOURCE TYPE
3.1. INSOURCED INTRAOPERATIVE NEUROMONITORING
3.2. OUTSOURCED INTRAOPERATIVE NEUROMONITORING
4.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY METHODOLOGY
4.1. EEG MONITORING
4.2. EMG MONITORING
4.3. EP MONITORING
4.3.1.
SEP MONITORING
4.3.2.
TCMEP MONITORING
4.3.3.
BAEP MONITORING
4.3.4.
VEP MONITORING
5.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY APPLICATIONS
5.1. SPINAL SURGERY
5.2. ENT SURGERY
5.3. NEUROSURGERY
5.4. VASCULAR SURGERY
5.5. ORTHOPEDIC SURGERY
5.6. OTHER SURGERIES
6.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY PRODUCTS &
SERVICES
6.1. SYSTEMS
6.2. ACCESSORIES
6.3. SERVICES
7.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY END-USERS
7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS (ASCs)
8.
INTRAOPERATIVE NEUROMONITORING MARKET - REGIONAL OUTLOOK
8.1. NORTH AMERICA
8.1.1.
MARKET BY SOURCE
8.1.2.
MARKET BY METHODOLOGY
8.1.3.
MARKET BY APPLICATIONS
8.1.4.
MARKET BY PRODUCTS & SERVICES
8.1.5.
MARKET BY END-USERS
8.1.6.
COUNTRY ANALYSIS
8.1.6.1.
UNITED STATES
8.1.6.2.
CANADA
8.2. EUROPE
8.2.1.
MARKET BY SOURCE
8.2.2.
MARKET BY METHODOLOGY
8.2.3.
MARKET BY APPLICATIONS
8.2.4.
MARKET BY PRODUCTS & SERVICES
8.2.5.
MARKET BY END-USERS
8.2.6.
COUNTRY ANALYSIS
8.2.6.1.
UNITED KINGDOM
8.2.6.2.
GERMANY
8.2.6.3.
FRANCE
8.2.6.4.
SPAIN
8.2.6.5.
ITALY
8.2.6.6.
RUSSIA
8.2.6.7.
REST OF EUROPE
8.3. ASIA-PACIFIC
8.3.1.
MARKET BY SOURCE
8.3.2.
MARKET BY METHODOLOGY
8.3.3.
MARKET BY APPLICATIONS
8.3.4.
MARKET BY PRODUCTS & SERVICES
8.3.5.
MARKET BY END-USERS
8.3.6.
COUNTRY ANALYSIS
8.3.6.1.
CHINA
8.3.6.2.
JAPAN
8.3.6.3.
INDIA
8.3.6.4.
SOUTH KOREA
8.3.6.5.
ASEAN COUNTRIES
8.3.6.6.
AUSTRALIA & NEW ZEALAND
8.3.6.7.
REST OF ASIA-PACIFIC
8.4. LATIN AMERICA
8.4.1.
MARKET BY SOURCE
8.4.2.
MARKET BY METHODOLOGY
8.4.3.
MARKET BY APPLICATIONS
8.4.4.
MARKET BY PRODUCTS & SERVICES
8.4.5.
MARKET BY END-USERS
8.4.6.
COUNTRY ANALYSIS
8.4.6.1.
BRAZIL
8.4.6.2.
MEXICO
8.4.6.3.
REST OF LATIN AMERICA
8.5. MIDDLE EAST AND AFRICA
8.5.1.
MARKET BY SOURCE
8.5.2.
MARKET BY METHODOLOGY
8.5.3.
MARKET BY APPLICATIONS
8.5.4.
MARKET BY PRODUCTS & SERVICES
8.5.5.
MARKET BY END-USERS
8.5.6.
COUNTRY ANALYSIS
8.5.6.1.
THE UNITED ARAB EMIRATES
8.5.6.2.
TURKEY
8.5.6.3.
SAUDI ARABIA
8.5.6.4.
SOUTH AFRICA
8.5.6.5.
REST OF MIDDLE EAST & AFRICA
9.
COMPETITIVE LANDSCAPE
9.1. ACCURATE NEUROMONITORING
9.2. INOMED MEDIZINTECHNIK GMBH
9.3. CADWELL
9.4. MOBERG RESEARCH, INC. (DAYONE MEDICAL LLC)
9.5. CNS NEUROMONITORING
9.6. COMPUTATIONAL DIAGNOSTICS
9.7. EMOTIV
9.8. INTRANERVE
9.9. MEDSURANT MONITORING
9.10.
MEDTRONIC
9.11.
NATUS MEDICAL
9.12.
SPECIALTYCARE
9.13.
NEUROMONITORING TECHNOLOGIES
9.14.
NEUROSENTINEL
9.15.
NIHON KOHDEN
9.16.
NUVASIVE
9.17.
CHECKPOINT SURGICAL
9.18.
ZYNEX
9.19.
ORIMTEC
10. RESEARCH METHODOLOGY & SCOPE
10.1.
RESEARCH SCOPE & DELIVERABLES
10.1.1.
OBJECTIVES OF STUDY
10.1.2.
SCOPE OF STUDY
10.2.
SOURCES OF DATA
10.2.1.
PRIMARY DATA SOURCES
10.2.2.
SECONDARY DATA SOURCES
10.3.
RESEARCH METHODOLOGY
10.3.1.
EVALUATION OF PROPOSED MARKET
10.3.2.
IDENTIFICATION OF DATA SOURCES
10.3.3.
ASSESSMENT OF MARKET DETERMINANTS
10.3.4.
DATA COLLECTION
10.3.5.
DATA VALIDATION & ANALYSIS
TABLE 1: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY GEOGRAPHY,
2019-2027 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE,
2019-2027 (IN $ MILLION)
TABLE 4: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY METHODOLOGY,
2019-2027 (IN $ MILLION)
TABLE 5: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATIONS,
2019-2027 (IN $ MILLION)
TABLE 6: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS &
SERVICES, 2019-2027 (IN $ MILLION)
TABLE 7: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY END-USERS,
2019-2027 (IN $ MILLION)
TABLE 8: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY GEOGRAPHY,
2019-2027 (IN $ MILLION)
TABLE 9: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 10: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
SOURCE, 2019-2027 (IN $ MILLION)
TABLE 11: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
METHODOLOGY, 2019-2027 (IN $ MILLION)
TABLE 12: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
APPLICATIONS, 2019-2027 (IN $ MILLION)
TABLE 13: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
PRODUCTS & SERVICES, 2019-2027 (IN $ MILLION)
TABLE 14: NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
END-USERS, 2019-2027 (IN $ MILLION)
TABLE 15: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY,
2019-2027 (IN $ MILLION)
TABLE 16: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE,
2019-2027 (IN $ MILLION)
TABLE 17: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY METHODOLOGY,
2019-2027 (IN $ MILLION)
TABLE 18: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATIONS,
2019-2027 (IN $ MILLION)
TABLE 19: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS
& SERVICES, 2019-2027 (IN $ MILLION)
TABLE 20: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END-USERS,
2019-2027 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE,
2019-2027 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
METHODOLOGY, 2019-2027 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
APPLICATIONS, 2019-2027 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
PRODUCTS & SERVICES, 2019-2027 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
END-USERS, 2019-2027 (IN $ MILLION)
TABLE 27: LATIN AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 28: LATIN AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE,
2019-2027 (IN $ MILLION)
TABLE 29: LATIN AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
METHODOLOGY, 2019-2027 (IN $ MILLION)
TABLE 30: LATIN AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
APPLICATIONS, 2019-2027 (IN $ MILLION)
TABLE 31: LATIN AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
PRODUCTS & SERVICES, 2019-2027 (IN $ MILLION)
TABLE 32: LATIN AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY
END-USERS, 2019-2027 (IN $ MILLION)
TABLE 33: MIDDLE EAST AND AFRICA INTRAOPERATIVE NEUROMONITORING MARKET,
BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND AFRICA INTRAOPERATIVE NEUROMONITORING MARKET,
BY SOURCE, 2019-2027 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA INTRAOPERATIVE NEUROMONITORING MARKET,
BY METHODOLOGY, 2019-2027 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND AFRICA INTRAOPERATIVE NEUROMONITORING MARKET,
BY APPLICATIONS, 2019-2027 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND AFRICA INTRAOPERATIVE NEUROMONITORING MARKET,
BY PRODUCTS & SERVICES, 2019-2027 (IN $ MILLION)
TABLE 38: MIDDLE EAST AND AFRICA INTRAOPERATIVE NEUROMONITORING MARKET,
BY END-USERS, 2019-2027 (IN $ MILLION)
FIGURE 1: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATIONS,
2018 & 2027 (IN %)
FIGURE 2: GLOBAL OUTSOURCED INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 3: GLOBAL EP MARKET, 2019-2027 (IN $ MILLION)
FIGURE 4: GLOBAL SPINAL SURGERY MARKET, 2019-2027 (IN $ MILLION)
FIGURE 5: GLOBAL SERVICES MARKET, 2019-2027 (IN $ MILLION)
FIGURE 6: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, 2019-2027 (IN $
MILLION)
FIGURE 7: PORTER’S FIVE FORCE ANALYSIS
FIGURE 8: MARKET ATTRACTIVENESS INDEX
FIGURE 9: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY INSOURCED
INTRAOPERATIVE NEUROMONITORING, 2019-2027 (IN $ MILLION)
FIGURE 10: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY OUTSOURCED
INTRAOPERATIVE NEUROMONITORING, 2019-2027 (IN $ MILLION)
FIGURE 11: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY EEG
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 12: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY EMG
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 13: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY EP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 14: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 15: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY TCMEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 16: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY BAEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 17: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY VEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 18: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SPINAL
SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 19: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY ENT SURGERY,
2019-2027 (IN $ MILLION)
FIGURE 20: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY
NEUROSURGERY, 2019-2027 (IN $ MILLION)
FIGURE 21: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY VASCULAR
SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 22: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY ORTHOPEDIC
SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 23: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY OTHER
SURGERIES, 2019-2027 (IN $ MILLION)
FIGURE 24: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SYSTEMS,
2019-2027 (IN $ MILLION)
FIGURE 25: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY ACCESSORIES,
2019-2027 (IN $ MILLION)
FIGURE 26: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SERVICES,
2019-2027 (IN $ MILLION)
FIGURE 27: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY HOSPITALS,
2019-2027 (IN $ MILLION)
FIGURE 28: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY AMBULATORY
SURGICAL CENTERS (ASCs), 2019-2027 (IN $ MILLION)
FIGURE 29: GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, REGIONAL
OUTLOOK, 2018 & 2027 (IN %)
FIGURE 30: UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 31: CANADA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 32: UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 33: GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN
$ MILLION)
FIGURE 34: FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 35: SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 36: ITALY INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 37: RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 38: REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 39: CHINA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 40: JAPAN INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 41: INDIA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 42: SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027
(IN $ MILLION)
FIGURE 43: ASEAN COUNTRIES INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 44: AUSTRALIA & NEW ZEALAND INTRAOPERATIVE NEUROMONITORING
MARKET, 2019-2027 (IN $ MILLION)
FIGURE 45: REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 46: BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 47: MEXICO INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 48: REST OF LATIN AMERICA INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 49: THE UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING
MARKET, 2019-2027 (IN $ MILLION)
FIGURE 50: TURKEY INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 51: SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027
(IN $ MILLION)
FIGURE 52: SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027
(IN $ MILLION)
FIGURE 53: REST OF MIDDLE EAST & AFRICA INTRAOPERATIVE
NEUROMONITORING MARKET, 2019-2027 (IN $ MILLION)